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 ABSTRACT 
 Background: Drug treatment is an important clinical process in primary care that is associated with risk of error and adverse 
events. 
 Objective: To review currently available research evidence on the topic and to develop a framework, which can help to guide 
improvement of medication safety. 
 Methods: Systematic reviews were performed on adverse drug events (ADE), their preventability, and on available tools and meth-
ods to improve medication safety with a particular focus on information technology. Consensus methods were used to develop a 
framework to guide the improvement of medication safety based on the ﬁ ndings of our literature review. 
 Results: The median prevalence rate of ADEs in primary care patients was 12.8%. Only a median of 16.5% of ADEs were prevent-
able and thus could be classiﬁ ed as medication errors. Our review of information technology interventions found that only about 
half of the studies found a reduction of medication errors. In both reviews, the wide range between studies emphasizes the neces-
sity of a validated medication error classiﬁ cation system. Another important aspect of medication safety appears to be a general 
lack of safety culture in primary care, which led us to the development of the Salzburg medication safety framework (SaMSaF), 
based on the MaPSaF tool to improve patient safety. The tool proved to be feasible and useful in a pilot study with several GP 
practices. 
 Conclusion: A number of tools and interventions to investigate and enhance medication safety have been identiﬁ ed. Further research 
is necessary to implement and evaluate current concepts. 
 Keywords:  Medication safety ,  adverse drug events ,  patient safety ,  primary care ,  literature review ,  LINNEAUS collaboration 
 INTRODUCTION 
 Improving safety of medication use has become an impor-
tant topic, not only in the hospital, but also in primary 
care. Due to the high frequency of drug pres criptions in 
primary care, the absolute number of adverse drug 
events (ADEs) is high, despite lower risk as compared to 
the hospital setting. Adverse drug events have been 
reported to occur at a rate of up to 25% of patients, under-
lining the necessity for improvement (1). However, we 
know little about the causes and preventability of these 
ADEs. Interventions involving information technology (IT) 
and pharmacist-led interventions may play an important 
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KEY MESSAGE:
 •  Medication safety is an issue of major concern in primary care. 
•  Most promising interventions to achieve optimization are clinical decision support, interprofessional collaboration between 
general practitioners and pharmacists, and tools to improve safety culture. 
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role to improve medication safety, but their impact seems 
inconsistent and overall moderate (2). 
 A systematic review on the evaluation of outpatient 
CPOE (computerized provider order entry) systems con-
cluded that evidence for the eﬀ ectiveness of these sys-
tems in outpatient settings is lacking (2). A systematic 
review including 38 studies revealed that pharmacist-led 
interventions were eﬀ ective in reducing hospital admis-
sions, although the eﬀ ect sizes were small (1). 
 Bearing in mind the lack of an overall systematic 
approach to medication safety in primary care, we aimed 
to review and collate the current knowledge on medica-
tion safety in primary care, and to develop frameworks, 
which guide improvement in this area. 
 METHODS 
 In the context of the LINNEAUS collaboration project, we 
performed a systematic review of studies on the preva-
lence and preventability of adverse drug events in ambula-
tory care, which was published in 2011 (3). We also 
conducted an observational study in Austrian general prac-
tices to document the types and frequency of medication 
errors in primary care patients with polypharmacy (4). 
 Epidemiological data on adverse drug events and 
medication errors are diﬃ  cult to interpret because dif-
ferent deﬁ nitions and methods are used in studies. 
Therefore, we set out to develop a consensus statement 
of deﬁ nitions in patient safety terms and to develop a 
classiﬁ cation system that is valid and useful for medica-
tion incident classiﬁ cation in primary care. We identiﬁ ed 
the existing types of interventions and currently used 
tools to improve medication safety in primary care in 
Europe in an extensive literature search (search up to 
2009) (3). As many interventions used information tech-
nology (IT), we conducted a second systematic review on 
IT interventions targeted at the improvement of medica-
tion safety in primary care (5). 
 Finally, we developed a standardized workshop, the 
Salzburg Medication Safety Framework (SaMSaF), based 
on the MaPSaF-tool to improve medication safety cul-
ture (6,7). 
 In this paper, we report on our review of the epide-
miology of ADEs, the framework that we used to classify 
ADEs, interventions to improve medication safety and a 
measure to assess safety culture in relation to medica-
tion use. 
 RESULTS 
 Epidemiology of adverse drug events and medication 
errors in primary care 
 Our systematic review (3) revealed the following results: 
The median ADE prevalence rate in ambulatory care 
patients was 12.8%, with a range from 2.8 to 34.7%. The 
median rate of preventable events in all ADEs (pADEs) in 
ambulatory care-based studies was 16.5%, (versus 52.9% 
in hospital-based studies), with a range from 11 – 27.5%. 
This rate of preventable ADEs decreased with age from 
a median of 15.8% in children to 13.6% in adults and 
9.9% in older patients. 
 In an observational study in Austrian general prac-
tices, we focussed on medication errors rather than 
adverse drug events and detected a mean of 2.7 medica-
tion errors per patient in patients with polypharmacy. 
These patients took an average of 9.1    3.0 drugs/day, 
and in 93.5% of the patients, at least one medication 
error could be detected (4). 
 Defi nitions and classifi cation of medication incident 
 Our systematic review and the large span of prevalence 
rates — due to diﬀ erent study designs, deﬁ nitions, 
denominators, and settings — make clear that epidemio-
logical as well as interventional research in medication 
safety requires a consensus on deﬁ nitions and method-
ology. We therefore developed the following deﬁ nitions 
of medication errors/ADEs and pADEs within the LIN-
NEAUS collaboration (6), of which the most relevant are 
the following: 
 NCC MERP deﬁ nition of medication errors (7):  ‘ any  •
preventable event that may cause or lead to inap-
propriate medication use or patient harm. ’ 
 ADE (adverse drug event) deﬁ nition of Bates et  al. (8):  •
 ‘ An injury resulting from medical intervention related 
to a drug. ’ 
 Preventable ADE (pADE) — Adverse drug events are  •
injuries resulting from drug use and, therefore, consti-
tute clinical outcomes. Adverse drug events associated 
with a medication error are considered preventable, 
whereas those not associated with a medication error 
are considered non-preventable (9). 
 Based on these definitions we developed a  ‘ classifica-
tion of medication incidents in primary care ’ (CMIPC) 
for usage by general practitioners and pharmacists. 
The CMIPC included five classification categories 
(discrimination between ADE and pADE, severity, 
process level at which the incident occurred, problem 
type, and main cause) and showed acceptable inter-
rater agreement in a validation study with GPs and 
pharmacists (3). 
 Interventions to improve medication safety 
 In our literature search for tools and interventions to 
improve medication safety in Europe, we identiﬁ ed 
16 tools and ﬁ ve educational interventions from nine 
diﬀ erent European countries, of which the majority 
were lists of inappropriate medication for the elderly or 
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 In the systematic review of interventions to improve 
medication safety, we focused on randomized controlled 
trials (RCTs) investigating information technology for the 
improvement of medication safety (5). This review 
showed that only in ﬁ ve of the ten RCTs included, a 
reduction of medication errors was achieved. CDS (clini-
cal decision support) systems were most eﬀ ective if they 
focused on a limited number of relevant drugs. 
 The impact of CDS on the initiation of recommended 
medication seemed larger than on the discontinuation 
of inappropriate pre-existing medication (10). Physicians 
tended to stop the CDS tool or to override alerts if there 
was poor signal-to-noise ratio (i.e. there were many 
alerts but only a few of them of clinical relevance), if 
alerts were judged as irrelevant, or if they were repeat-
edly shown (11). Alert fatigue appears to be the most 
probable explanation why computer-triggered alerts 
were not superior to on-demand alerts. Furthermore, 
the positive results of pharmacist-led interventions indi-
cate that IT interventions combined with inter-profes-
sional communication may be most eﬀ ective. However, 
alert fatigue is also a problem in computerized decision 
support systems used by pharmacists to provide recom-
mendations on drug treatments. 
 Another ﬁ nding in our systematic review was that 
some errors were related to the insuﬃ  cient reliability of 
or errors induced by information technology. These 
errors raise safety concerns that must be seen as a threat 
to patients by e-iatrogenesis (12). 
 The Salzburg medication safety framework 
 Our results regarding the limited eﬀ ectiveness of the 
tools and educational interventions we studied led to 
the conclusion that apart from available tools there is 
a need to strengthen  ‘ safety culture ’ as an important 
human resource for safety enhancement. We, there-
fore, developed a tool to improve safety culture in 
respect to medication safety. The Salzburg medication 
safety framework (SaMSaF) is based on the Man-
chester patient safety framework (MaPSaF), which has 
been developed to address general safety culture in 
primary care (7,13). We adapted MaPSaF to focus spe-
ciﬁ cally on medication safety. SaMSaF is constructed 
as a workshop held in a GP surgery and sets out with 
all members rating the practice ’ s attitude towards 
medication safety regarding nine dimensions of 
quality and safety. The rating extends over ﬁ ve catego-
ries from  ‘ pathologic ’ to  ‘ generative ’ (see Figure 1). 
The surgery staﬀ  discusses the ratings, and interven-
tions to improve medication safety in the particular 
practice are developed by the staﬀ  itself. The tool was 
piloted in three general practices in Salzburg and 
Bavaria, and results of the pilot tests found SaMSaF 
to be feasible and useful. Community pharmacists 
have developed a similar tool for use, and further 
research should be carried out formally to assess 
SaMSaF as a potential tool to improve medication 
safety in primary care (8). 




























1. Overall commitment to quality
2. Priority given to medication safety
3. Perceptions of the causes of medication safety
4. Investigating medication safety incidents
5. Learning following a medication safety incident
6. Communication about medication safety issues
7. Personnel management and medication safety
8. Staff education and training about medication
safety issues
9. Team working around medication safety issues
 Figure 1. The Salzburg medication safety framework (SaMSaF). SaMSaF is based on the Manchester patient safety framework (MaPSaF). Practice 
staﬀ  carries out a self-evaluation of their culture for each of the dimensions and rate their status in relation to this. The terms are explained in the 
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tional outreaches or other approaches, is probably of 
secondary importance. 
 CONCLUSION 
 Adverse drug events in primary care are one of the most 
researched areas in relation to improving patient safety 
in primary care. There are distinct areas where the 
research evidence suggests that improvements can be 
made within the primary care setting — for example well-
targeted clinical decision support systems. The impor-
tance of interprofessional working between pharmacists 
and general practitioners together with practice based 
safety culture awareness, using tools like the SaMSaF, 
cannot be overlooked in improving medication safety in 
primary care. 
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 DISCUSSION 
 Main fi ndings 
 The literature reviews, studies and frameworks in this 
paper highlight the importance of medication safety in 
primary care and the need to develop eﬀ ective inter-
ventions to improve it. We found a substantial risk of 
error and adverse drug events in primary care, which 
translates into high numbers at the national level 
because of the high number of drug prescriptions in 
primary care. Computerized prescriber order entry sys-
tems with clinical decision support and involvement of 
pharmacists are two methods to improve medication 
safety, which can be eﬀ ective but need to be improved 
to optimize their impact. Standardization of language is 
recommended to facilitate further development of the 
ﬁ eld. 
 Challenges 
 One of the most important challenges will be to improve 
the eﬀ ectiveness of CDS by reducing the alert burden to 
only clinically relevant alerts. Decision support systems 
should provide valid data on safer prescription and 
should, therefore, be restricted to relevant evidence-
based recommendations, avoiding those of minor impor-
tance. Comprehensive valid drug databases still need to 
be developed or improved. Eventually, to further facili-
tate judgment about risk relative to beneﬁ t; CDS may 
also be required to integrate additional clinical data and 
laboratory information in order to tailor recommenda-
tions to the individual patient (4). 
 Another important step towards more medication 
safety may be the improvement of interprofessional col-
laboration. A recent cluster randomized trial compared 
the eﬀ ectiveness and cost-eﬀ ectiveness of a pharmacist-
led IT-based intervention with simple feedback to the 
physicians in reducing rates of clinically important errors 
in medicines management in 72 English general prac-
tices. The main outcomes of interest were prescribing 
errors and medication monitoring errors at six and 
12 months following the intervention. As a result, the 
prevalence of prescriptions with prescribing or monitor-
ing errors dropped signiﬁ cantly, with odds ratios between 
0.51 and 0.73 compared to the control group (14). 
 Our somewhat disappointing results regarding the 
eﬀ ectiveness of IT-interventions and the work of the 
LINNEAUS Euro-PC collaboration on safety culture 
make it very clear that no tool or intervention of any 
type will be eﬀ ective without physician and health pro-
fessional awareness and interprofessional collabora-
tion. A proactive or generative attitude towards patient 
safety is essential to motivate health professionals to 
use tools to improve the safety of their patients. 
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